Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Immunology and Allergy Clinics of North America is Scopus-indexed (Q2, CiteScore 5.5), WoS SCIE. Published by W.B. Saunders.
Checked against the index lists dated .
ISSN 0889-8561Verify ISSN ↗1557-8607Verify ISSN ↗
Publisher: W.B. Saunders
Cost to publish: About US$3,360 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 97 / 234 | 58th | Q2 |
| Immunology | 110 / 243 | 54th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1987–present, best quartile Q2, CiteScore 5.5.
Immunology and Allergy Clinics of North America is Q2 in Immunology and Allergy (rank 97 of 234) and Q2 in Immunology (rank 110 of 243), by CiteScore 2025.
Immunology and Allergy Clinics of North America is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.5, which places it in quartile Q2 at the 58th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.785, quartile Q3, with an H-index of 83.
The publisher lists an article processing charge of about US$3,360 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Immunology and Allergy Clinics of North America is published by W.B. Saunders. Its print ISSN is 0889-8561 and its online ISSN is 1557-8607.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Immunology and Allergy Clinics of North America has an h-index of 92 and a 2-year mean of 1.85 citations per paper (OpenAlex). Its Scopus CiteScore is 5.5, quartile Q2. On 2-year citations it ranks #127 of 231 Scopus journals in Immunology and Allergy.
Immunology and Allergy Clinics of North America published 70 papers in 2025; its busiest recent year was 2024 with 84. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 91 research articles (2024–2026), authors are most often from United States (86.6%), Canada (4.2%) and Netherlands (1.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.